医疗科技投资者正以创新方式寻求退出策略。
Health tech investors are getting creative with exits
生物技术与制药领域的最新动态
Health tech investors are getting creative with exits
IL-17 stimulates erythropoiesis in vivo by amplifying the response of erythroid progenitors to erythropoietin
A colorful legacy of hybridization in wood-warblers includes frequent sharing of carotenoid genes among species and genera
Plasmid streamlining drives the extinction of antibiotic resistance plasmids under selection for horizontal transmission
Today's news in brief
Epilepsygtx's $33M advances focal epilepsy gene therapy
Citigroup Downgrades 10x Genomics to Neutral From Buy, Price Target is $18 - marketscreener.com
Roche hails giredestrant effect in ER-positive early-stage breast cancer - The Pharma Letter
Meta Pharmaceutical and Moyuan Pharmaceuticals divulge new LDHA inhibitors
Chinese scientists describe new CEACAM5-targeting antibody-drug conjugates
New opioid receptor agonists disclosed in Alphamol Science patent
Shanghai Best-Link Bioscience discovers new polymer-drug conjugates
Crapo, Cassidy propose enhanced ACA subsidy alternative
Pharma’s top deals in 2025
Zealand inks deal with OTR Therapeutics as it spells out broader metabolic disease ambitions
Thermo Fisher Scientific expands its bioprocessing capabilities in Asia - European Pharmaceutical Review
GRI touts IPF safety edge, lung function gains amid cash crunch
Zealand pens $2.5B oral cardiometabolic collab with fresh-faced Chinese biotech
FDA approves 1st nondrug, at-home treatment for depression
Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO